Yewei Wang

Yewei Wang

Auto-generated profile, based on publicly available information

Yewei Wang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DTDoudou Tang
Doudou Tang
MCMingjie Chen
Mingjie Chen
XHXinhua Huang
Xinhua Huang
GZGuicheng Zhang
Guicheng Zhang
LZLin Zeng
Lin Zeng
YWYewei Wang
Yewei Wang
Graphics are widely used to provide summarization of complex data in scientific publications. Although there are many tools available for drawing graphics, their use is limited by programming skills, costs, and platform specificities. Here, we presented a freely accessible easy-to-use web server named SRplot that integrated more than a hundred of commonly used data visualization and graphing functions together. It can be run easily using all Web browsers and there are no strong requirements on the computing power of users’ machines. With a user-friendly graphical interface, users can simply paste the contents of the input file into the text box according to the defined file format. Modification operations can be easily performed, and graphs can be generated in real-time. The resulting graphs can be easily downloaded in bitmap (PNG or TIFF) or vector (PDF or SVG) format in publication quality. The website is updated promptly and continuously. Functions in SRplot have been improved, optimized and updated depend on feedback and suggestions from users. The graphs prepared with SRplot have been featured in more than five hundred peer-reviewed publications. The SRplot web server is now freely available at http://www.bioinformatics.com.cn/SRplot.

1 January 2021 in Annals of Medicine
Verified
Journal Article
Open access
DZDengqin Zhu
Dengqin Zhu
DTDoudou Tang
Doudou Tang
XCXiaoshan Chai
Xiaoshan Chai
GZGuangsen Zhang
Guangsen Zhang
YWYewei Wang
Yewei Wang
Acute leukemia (AL) occurring in pregnancy is extremely rare, and its treatment is a clinical dilemma.We retrospectively reviewed the medical records of our hospital from 2010 to 2019.Twenty-one pa...

30 April 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
YWYewei Wang
Yewei Wang
MUMd Ashik Ullah
Md Ashik Ullah
OWOlivia G. Waltner
Olivia G. Waltner
SBShruti S. Bhise
Shruti S. Bhise
KEKathleen S. Ensbey
Kathleen S. Ensbey
GHGeoffrey R. Hill
Geoffrey R. Hill
Calcineurin inhibitors (CNIs) constitute the backbone of modern acute graft-versus-host disease (aGVHD) prophylaxis regimens but have limited efficacy in the prevention and treatment of chronic GVHD (cGVHD). We investigated the effect of CNIs on immune tolerance after stem cell transplantation with discovery-based single-cell gene expression and T cell receptor (TCR) assays of clonal immunity in tandem with traditional protein-based approaches and preclinical modeling. While cyclosporin and tacrolimus suppressed the clonal expansion of CD8 + T cells during GVHD, alloreactive CD4 + T cell clusters were preferentially expanded. Moreover, CNIs mediated reversible dose-dependent suppression of T cell activation and all stages of donor T cell exhaustion. Critically, CNIs promoted the expansion of both polyclonal and TCR-specific alloreactive central memory CD4 + T cells (T CM ) with high self-renewal capacity that mediated cGVHD following drug withdrawal. In contrast to posttransplant cyclophosphamide (PT-Cy), CSA was ineffective in eliminating IL-17A–secreting alloreactive T cell clones that play an important role in the pathogenesis of cGVHD. Collectively, we have shown that, although CNIs attenuate aGVHD, they paradoxically rescue alloantigen-specific T CM , especially within the CD4 + compartment in lymphoid and GVHD target tissues, thus predisposing patients to cGVHD. These data provide further evidence to caution against CNI-based immune suppression without concurrent approaches that eliminate alloreactive T cell clones.

17 August 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
DTDoudou Tang
Doudou Tang
YLYujiao Luo
Yujiao Luo
YJYafeng Jiang
Yafeng Jiang
PHPiao Hu
Piao Hu
HPHongling Peng
Hongling Peng
YWYewei Wang
Yewei Wang
Uncontrolled proliferation is the hallmark of cancer cells. Previous studies mainly focused on the role of protein-coding genes in cancer cell proliferation. Emerging evidence showed that long non-coding RNAs (lncRNAs) also play critical roles in cancer cell proliferation and growth. LncRNA KCNQ1OT1 is found to contribute to carcinogenesis, but its role in acute promyelocytic leukemia (APL) is unclear. In this study, by analyzing data from Gene Expression Omnibus, The Cancer Genome Atlas database and our clinical samples, we found that KCNQ1OT1 was selectively highly expressed in APL. Functional assays demonstrated that knockdown of KCNQ1OT1 reduced APL cell proliferation and increased apoptosis. Further evidence showed that KCNQ1OT1 was mainly located in the cytoplasm of APL patient-derived NB4 cells and APL patient bone marrow samples. Mechanistically, KCNQ1OT1 bound to RNA binding protein FUS, and silencing either KCNQ1OT1 or FUS reduced the expression level and stability of MAP3K1 mRNA. Whereas KCNQ1OT1 and FUS did not affect each other. Importantly, knockdown of MAP3K1 impaired APL cell proliferation. Finally, c-Myc transactivated KCNQ1OT1 in APL cells through binding to its promoter while knockdown of c-Myc decreased KCNQ1OT1 expression. Our results not only revealed that c-Myc transactivated KCNQ1OT1 and upregulated KCNQ1OT1 promoted APL cell proliferation, but also demonstrated that KCNQ1OT1 bound to FUS to synergistically stabilize MAP3K1 mRNA, thus facilitating APL cell proliferation. This study established a previously unidentified role of KCNQ1OT1 in the development of APL, and KCNQ1OT1 may serve as a potential therapeutic target for APL.

1 May 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YWYewei Wang
Yewei Wang
LFLei Fu
Lei Fu
ASAilian Sun
Ailian Sun
DTDoudou Tang
Doudou Tang
YXYunxiao Xu
Yunxiao Xu
GZGuangsen Zhang
Guangsen Zhang

23 May 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
JWJia Wan
Jia Wan
LZLi Zhang
Li Zhang
TLTang Liu
Tang Liu
YWYewei Wang
Yewei Wang
Genetic evaluations of chinese patients with odontohypophosphatasia resulting from heterozygosity for mutations in the tissue-non-specific alkaline phosphatase gene Genetic evaluations of Chinese patients with odontohypophosphatasia resulting from heterozygosity for mutations in the tissue-non-specific alkaline phosphatase gene